JP2012097086A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012097086A5 JP2012097086A5 JP2011256451A JP2011256451A JP2012097086A5 JP 2012097086 A5 JP2012097086 A5 JP 2012097086A5 JP 2011256451 A JP2011256451 A JP 2011256451A JP 2011256451 A JP2011256451 A JP 2011256451A JP 2012097086 A5 JP2012097086 A5 JP 2012097086A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody preparation
- ultrafiltration
- antibody
- subjecting
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 claims 6
- 238000000108 ultra-filtration Methods 0.000 claims 3
- 238000011026 diafiltration Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000013060 ultrafiltration and diafiltration Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60909204P | 2004-09-09 | 2004-09-09 | |
| US60/609,092 | 2004-09-09 | ||
| US11/220,362 | 2005-09-06 | ||
| US11/220,362 US20060051347A1 (en) | 2004-09-09 | 2005-09-06 | Process for concentration of antibodies and therapeutic products thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007531302A Division JP5210633B2 (ja) | 2004-09-09 | 2005-09-08 | 抗体濃縮法とその治療用製品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012097086A JP2012097086A (ja) | 2012-05-24 |
| JP2012097086A5 true JP2012097086A5 (cg-RX-API-DMAC7.html) | 2013-02-07 |
| JP5426641B2 JP5426641B2 (ja) | 2014-02-26 |
Family
ID=35996499
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007531302A Expired - Lifetime JP5210633B2 (ja) | 2004-09-09 | 2005-09-08 | 抗体濃縮法とその治療用製品 |
| JP2011256451A Expired - Lifetime JP5426641B2 (ja) | 2004-09-09 | 2011-11-24 | 抗体濃縮法とその治療用製品 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007531302A Expired - Lifetime JP5210633B2 (ja) | 2004-09-09 | 2005-09-08 | 抗体濃縮法とその治療用製品 |
Country Status (32)
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE442862T2 (de) * | 2000-10-12 | 2009-10-15 | Genentech Inc | Niederviskose konzentrierte proteinformulierungen |
| US8703126B2 (en) | 2000-10-12 | 2014-04-22 | Genentech, Inc. | Reduced-viscosity concentrated protein formulations |
| BRPI0403964B8 (pt) * | 2003-04-04 | 2021-05-25 | Genentech Inc | formulações líquidas estáveis, artigo manufaturado e uso dessas formulações para o tratamento de disfunção mediada por ige |
| WO2005073367A1 (en) | 2004-01-30 | 2005-08-11 | Zymenex A/S | Production and purification of recombinant arylsulfatase a |
| DK2072040T3 (da) | 2004-05-12 | 2013-07-29 | Baxter Healthcare Sa | Terapeutisk anvendelse af nukleinsyremikrokugler |
| US7884085B2 (en) | 2004-05-12 | 2011-02-08 | Baxter International Inc. | Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| EP3351269B1 (en) | 2005-06-14 | 2020-01-29 | Amgen Inc. | Self-buffering protein formulations |
| DK2007506T3 (da) * | 2006-03-31 | 2014-06-16 | Danisco Us Inc | Tangentialstrømningsfiltreringsapparater, -systemer og -fremgangsmådertil separering af forbindelser |
| NZ568728A (en) * | 2006-04-04 | 2011-09-30 | Shire Pharmaceuticals Ireland Ltd | A process for concentration of a aryl sulfatase A |
| EP2142565A4 (en) | 2007-03-29 | 2010-03-31 | Abbott Lab | CRYSTALLINE HUMAN ANTI-IL-12 ANTIBODIES |
| AU2008277886B8 (en) | 2007-07-17 | 2013-08-01 | F. Hoffmann-La Roche Ag | Variable tangential flow filtration |
| US20100249384A1 (en) * | 2007-11-29 | 2010-09-30 | Stefan Hepbildikler | Immunoglobulin aggregates |
| CN101969971A (zh) * | 2007-11-30 | 2011-02-09 | 雅培制药有限公司 | 蛋白制剂及其制备方法 |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| PL2271382T3 (pl) | 2008-04-15 | 2013-08-30 | Grifols Therapeutics Inc | Dwuetapowa ultrafiltracja/diafiltracja |
| WO2009139624A1 (en) * | 2008-05-15 | 2009-11-19 | Mucovax Holding B.V. | Process for producing milk fractions rich in secretory immunoglobulins |
| WO2010066634A1 (en) * | 2008-12-09 | 2010-06-17 | F. Hoffmann-La Roche Ag | Method for obtaining an excipient-free antibody solution |
| WO2010090864A2 (en) * | 2009-01-21 | 2010-08-12 | Smartflow Technologies, Inc. | Optimization of separation for viscous suspensions |
| AU2010221156A1 (en) * | 2009-03-06 | 2011-09-22 | Genentech, Inc. | Antibody formulation |
| ES2733346T3 (es) * | 2009-03-24 | 2019-11-28 | Wyeth Llc | Evaporación por membrana para generar medicamentos proteicos altamente concentrados |
| SG176256A1 (en) * | 2009-05-27 | 2012-01-30 | Baxter Int | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| HUE029197T2 (en) | 2009-09-29 | 2017-02-28 | Hoffmann La Roche | Adjustment of dissolved buffer by pre-filtration to a high concentration immunoglobulin formulation |
| HRP20161693T1 (hr) | 2009-10-01 | 2017-02-24 | F. Hoffmann - La Roche Ag | Završno filtriranje imunoglobulina u više koraka |
| JP6078344B2 (ja) | 2010-02-04 | 2017-02-08 | ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト | 免疫グロブリン製剤 |
| HUE047173T2 (hu) | 2010-03-01 | 2020-04-28 | Bayer Healthcare Llc | Optimalizált monoklonális ellenanyagok szöveti faktor útvonal inhibitor (TFPI) ellen |
| US10336992B2 (en) | 2011-07-08 | 2019-07-02 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase A |
| BR112014004828B8 (pt) * | 2011-09-01 | 2022-03-29 | Chugai Pharmaceutical Co Ltd | Métodos para preparação de composições compreendendo anticorpos ou proteínas concentradas por ultrafiltração |
| AR089434A1 (es) | 2011-12-23 | 2014-08-20 | Genentech Inc | Procedimiento para preparar formulaciones con alta concentracion de proteinas |
| US20130281355A1 (en) | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| US9592297B2 (en) | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
| US8613919B1 (en) | 2012-08-31 | 2013-12-24 | Bayer Healthcare, Llc | High concentration antibody and protein formulations |
| JP2016504344A (ja) * | 2012-12-28 | 2016-02-12 | ノヴォ ノルディスク アー／エス | 高温デッドエンド抗体ろ過 |
| CN112126634A (zh) | 2013-01-09 | 2020-12-25 | 夏尔人类遗传性治疗公司 | 含用于纯化芳基硫酸酯酶a的方法 |
| DE102013001628A1 (de) | 2013-01-30 | 2014-07-31 | Fresenius Medical Care Deutschland Gmbh | Verfahren zur Bereitstellung eines Konzentrats |
| WO2015175679A2 (en) | 2014-05-13 | 2015-11-19 | Amgen Inc. | Process control systems and methods for use with filters and filtration processes |
| WO2015195453A2 (en) * | 2014-06-16 | 2015-12-23 | Emd Millipore Corporation | Methods for increasing the capacity of flow-through processes |
| WO2015195452A2 (en) * | 2014-06-16 | 2015-12-23 | Emd Millipore Corporation | Single-pass filtration systems and processes |
| EP2957335B1 (en) * | 2014-06-16 | 2020-05-27 | EMD Millipore Corporation | Single-pass filtration systems and processes |
| EP4144434B1 (en) * | 2014-06-16 | 2024-04-17 | EMD Millipore Corporation | Single-pass filtration systems and processes |
| KR102064888B1 (ko) | 2014-06-25 | 2020-01-10 | 이엠디 밀리포어 코포레이션 | 밀집한 나권형 필터 엘리먼트, 모듈 및 시스템 |
| SG10202006102UA (en) | 2014-08-29 | 2020-07-29 | Emd Millipore Corp | Processes For Filtering Liquids Using Single Pass Tangential Flow Filtration Systems AndTangential Flow Filtration Systems With Recirculation of Retentate |
| ES2926043T3 (es) | 2014-08-29 | 2022-10-21 | Emd Millipore Corp | Sistemas de filtración de flujo tangencial de paso único y sistemas de filtración de flujo tangencial con recirculación de retenido |
| AU2015335743B2 (en) | 2014-10-23 | 2020-12-24 | Amgen Inc. | Reducing viscosity of pharmaceutical formulations |
| EP3226895B1 (en) | 2014-12-03 | 2020-07-22 | CSL Behring AG | Pharmaceutical product with increased stability comprising immunoglobulins |
| GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| MX2018003298A (es) * | 2015-09-22 | 2018-06-20 | Pfizer | Metodo para preparar una formulacion de proteinas terapeuticas y formulacion de anticuerpos producida por tal metodo. |
| WO2017213892A1 (en) | 2016-06-09 | 2017-12-14 | Emd Millipore Corporation | Radial-path filter elements, systems and methods of using same |
| SG11201901220XA (en) * | 2016-08-16 | 2019-03-28 | Genzyme Corp | Methods of processing a fluid including a recombinant therapeutic protein and use thereof |
| US11572385B2 (en) * | 2016-08-17 | 2023-02-07 | Boehringer Ingelheim International Gmbh | Process for the preparation of concentrated liquid formulations containing biomolecules |
| JP6884858B2 (ja) | 2016-10-21 | 2021-06-09 | アムジエン・インコーポレーテツド | 医薬製剤及びその製造方法 |
| JP7377596B2 (ja) | 2017-02-22 | 2023-11-10 | アムジエン・インコーポレーテツド | 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法 |
| CN107952280A (zh) * | 2017-11-28 | 2018-04-24 | 安徽东方帝维生物制品股份有限公司 | 一种兽用疫苗无菌超滤浓缩装置及方法 |
| WO2019132418A1 (ko) * | 2017-12-27 | 2019-07-04 | ㈜셀트리온 | 투석 여과 방법 |
| JP7465215B2 (ja) * | 2018-04-12 | 2024-04-10 | アムジェン インコーポレイテッド | 安定なタンパク質組成物を製造する方法 |
| TWI898645B (zh) * | 2018-05-04 | 2025-09-21 | 美商健臻公司 | 灌注式細胞培養裝置 |
| JP7425041B2 (ja) * | 2018-08-10 | 2024-01-30 | アムジエン・インコーポレーテツド | 抗体医薬製剤を作製する方法 |
| EP3837273B1 (en) | 2018-08-14 | 2025-09-24 | Bristol-Myers Squibb Company | Improved protein recovery |
| TWI871300B (zh) * | 2019-01-28 | 2025-02-01 | 美商安進公司 | 藉由將藥物物質和藥物產品過程整體化的生物製劑製造之連續製造過程 |
| AU2020223376A1 (en) * | 2019-02-15 | 2021-07-22 | Just - Evotec Biologics, Inc. | Automated biomanufacturing systems, facilities, and processes |
| HUE056569T2 (hu) * | 2019-07-31 | 2022-02-28 | Catalent Uk Swindon Zydis Ltd | Sûrûség-áramlásmérõ gyógyászati készítmény adagolásához |
| CN111018968B (zh) * | 2019-12-16 | 2021-07-27 | 兴盟生物医药(苏州)有限公司 | 一种通过超滤浓缩制备高浓度抗体制剂的方法 |
| JP7338527B2 (ja) * | 2020-03-19 | 2023-09-05 | 東レ株式会社 | 体液検体中のアレルゲン特異的ＩｇＥ抗体の検出方法 |
| CN111944046B (zh) * | 2020-08-28 | 2021-04-09 | 江苏荃信生物医药有限公司 | 高浓度、低粘度抗人il-23单克隆抗体溶液的制备方法 |
| US20230374064A1 (en) * | 2020-10-05 | 2023-11-23 | Bristol-Myers Squibb Company | Methods for concentrating proteins |
| CA3199735A1 (en) | 2020-11-23 | 2022-05-27 | Chris Klopp | Filtration systems,components and methods |
| KR20230155498A (ko) * | 2021-03-08 | 2023-11-10 | 베링거 인겔하임 인터내셔날 게엠베하 | 단일 통과 역류 정용여과를 위한 시스템 및 방법 |
| CN114014929B (zh) * | 2021-11-04 | 2022-07-19 | 江苏荃信生物医药股份有限公司 | 一种抗人白介素-33单克隆抗体浓缩溶液的制备方法 |
| MX2024010419A (es) | 2022-02-25 | 2024-09-05 | Amgen Inc | Metodos de preparacion de sustancias farmacologicas liquidas de alta concentracion. |
| CN115261193A (zh) * | 2022-05-31 | 2022-11-01 | 利穗科技(苏州)有限公司 | 一种生物制品浓缩系统及其工艺 |
| AU2023306365A1 (en) * | 2022-07-12 | 2025-02-13 | Beone Medicines I Gmbh | Preparation methods for a highly concentrated pd1 antibody solution by ultrafiltration/diafiltration (uf/df) |
| CN115873064A (zh) * | 2022-09-27 | 2023-03-31 | 英脉生物医药(杭州)有限公司 | 高浓度蛋白样品的制备装置及方法 |
| AU2024260197A1 (en) * | 2023-04-25 | 2025-11-13 | Enzene Biosciences Limited | In line cleaning in place process for alternating tangential flow filter |
| US12030959B1 (en) | 2023-07-05 | 2024-07-09 | Genentech, Inc. | Anti-IgE antibody therapy for multiple food allergies |
| CA3237624A1 (en) | 2023-07-28 | 2025-04-24 | Genentech, Inc. | NEW USES FOR OMALIZUMAB |
| WO2025101602A1 (en) | 2023-11-07 | 2025-05-15 | Amgen Inc. | Methods of analyzing amino acid content of a therapeutic protein |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5625616B2 (cg-RX-API-DMAC7.html) | 1973-10-08 | 1981-06-13 | ||
| FR2459619B1 (fr) | 1979-06-26 | 1983-07-29 | Agronomique Inst Nat Rech | Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede |
| US4362661A (en) | 1979-08-09 | 1982-12-07 | Teijin Limited | Immunoglobulin composition having a high monomer content, and process for production thereof |
| US4374763A (en) | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IN161706B (cg-RX-API-DMAC7.html) * | 1983-10-05 | 1988-01-16 | Solco Basel Ag | |
| US4786501A (en) * | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
| US4756696A (en) | 1985-12-06 | 1988-07-12 | Amp Incorporated | Solder joint inspection feature for surface mount connectors |
| GB8628104D0 (en) * | 1986-11-25 | 1986-12-31 | Connaught Lab | Pasteurization of immunoglobin solutions |
| JPS6485829A (en) | 1987-09-29 | 1989-03-30 | Aisin Aw Co | Transmission for four-wheel drive vehicle |
| JPH01268646A (ja) | 1988-04-20 | 1989-10-26 | Meiji Milk Prod Co Ltd | 抗腫瘍剤 |
| GB2218703B (en) | 1988-05-10 | 1992-10-28 | Sumitomo Chemical Co | Human monoclonal antibody to p.aeruginosa: its production and use |
| US4897465A (en) | 1988-10-12 | 1990-01-30 | Abbott Laboratories | Enrichment and concentration of proteins by ultrafiltration |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| WO1990006764A1 (en) | 1988-12-15 | 1990-06-28 | Invitron Corporation | Use of basic amino acids to solubilize immunoglobulins |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
| NL9001650A (nl) | 1990-07-19 | 1992-02-17 | Ver Coop Melkind | Werkwijze voor de bereiding van een melkeiwit-isolaat. |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| WO1992003918A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5256294A (en) | 1990-09-17 | 1993-10-26 | Genentech, Inc. | Tangential flow filtration process and apparatus |
| JP2916947B2 (ja) | 1990-11-28 | 1999-07-05 | 興和株式会社 | Ｃｐｂ―ｉの安定化方法及び製剤組成物 |
| US6582959B2 (en) | 1991-03-29 | 2003-06-24 | Genentech, Inc. | Antibodies to vascular endothelial cell growth factor |
| JP2907603B2 (ja) * | 1991-09-09 | 1999-06-21 | 雪印乳業株式会社 | 新規生理活性ペプチド、該活性ペプチドを有効成分とする胃酸分泌抑制剤、抗潰瘍剤及び飲食品 |
| US6270757B1 (en) | 1994-04-21 | 2001-08-07 | Genetics Institute, Inc. | Formulations for IL-11 |
| US6372716B1 (en) | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
| US5580856A (en) | 1994-07-15 | 1996-12-03 | Prestrelski; Steven J. | Formulation of a reconstituted protein, and method and kit for the production thereof |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5707678A (en) | 1995-04-12 | 1998-01-13 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
| ATE390933T1 (de) | 1995-04-27 | 2008-04-15 | Amgen Fremont Inc | Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8 |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DK1516628T3 (da) * | 1995-07-27 | 2013-09-08 | Genentech Inc | Stabil, isotonisk lyofiliseret proteinformulering |
| DE19544393A1 (de) | 1995-11-15 | 1997-05-22 | Hoechst Schering Agrevo Gmbh | Synergistische herbizide Mischungen |
| DE19543737A1 (de) | 1995-11-24 | 1997-05-28 | Hoechst Ag | Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices |
| US5770700A (en) | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
| KR100236393B1 (ko) | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | 사람성장호르몬을 함유하는 의약제제 |
| TW518219B (en) | 1996-04-26 | 2003-01-21 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
| GB9610992D0 (en) * | 1996-05-24 | 1996-07-31 | Glaxo Group Ltd | Concentrated antibody preparation |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| US6172213B1 (en) | 1997-07-02 | 2001-01-09 | Genentech, Inc. | Anti-IgE antibodies and method of improving polypeptides |
| US5994511A (en) | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
| KR20010030665A (ko) | 1997-09-22 | 2001-04-16 | 세프라겐 코포레이션 | 유장 단백질의 순차적 분리법 및 그의 제제 |
| RU2140287C1 (ru) * | 1998-08-25 | 1999-10-27 | Государственное унитарное предприятие "Иммунопрепарат" | Способ получения альбумина |
| AU6405899A (en) | 1998-10-26 | 2000-05-15 | Galagen, Inc. | Soy and immunoglobulin compositions |
| JP2000247903A (ja) | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
| WO2001003515A1 (en) | 1999-07-07 | 2001-01-18 | New Zealand Co-Operative Dairy Company Limited | Method of obtaining protein isolates and concentrates from colostrum |
| CZ305123B6 (cs) | 1999-10-04 | 2015-05-13 | Novartis Vaccines And Diagnostics, Inc. | Způsob výroby kapalného farmaceutického prostředku |
| PT1314437E (pt) * | 2000-08-11 | 2014-08-29 | Chugai Pharmaceutical Co Ltd | Preparações estabilizadas contendo anticorpo |
| ATE442862T2 (de) * | 2000-10-12 | 2009-10-15 | Genentech Inc | Niederviskose konzentrierte proteinformulierungen |
| ES2184594B1 (es) | 2001-01-17 | 2004-01-01 | Probitas Pharma Sa | Procedimiento para la produccion de gammaglobulina g humana inactivada de virus. |
| DE60235013D1 (de) | 2001-07-25 | 2010-02-25 | Facet Biotech Corp | Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab |
| CA2466034C (en) | 2001-11-08 | 2012-12-18 | Protein Design Labs, Inc. | Stable aqueous pharmaceutical formulations of daclizumab antibodies |
| WO2003042344A2 (en) * | 2001-11-13 | 2003-05-22 | Genentech, Inc. | Apo2 ligand/trail formulations |
| PT1946776T (pt) | 2002-02-27 | 2017-03-17 | Immunex Corp | Composição de tnfr-fc estabilizada compreendendo arginina |
| WO2004001007A2 (en) * | 2002-06-21 | 2003-12-31 | Idec Pharmaceuticals Corporation | Buffered formulations for concentrating antibodies and methods of use thereof |
| WO2004042012A2 (en) * | 2002-11-01 | 2004-05-21 | Bayer Healthcare Llc | Process for concentration of macromolecules |
| GB0229444D0 (en) | 2002-12-18 | 2003-01-22 | Royal Free Hampstead Nhs Trust | Diagnostic method and assay kit |
| US20040167320A1 (en) * | 2003-02-24 | 2004-08-26 | Couto Daniel E. | Methods of tangential flow filtration and an apparatus therefore |
| BRPI0403964B8 (pt) * | 2003-04-04 | 2021-05-25 | Genentech Inc | formulações líquidas estáveis, artigo manufaturado e uso dessas formulações para o tratamento de disfunção mediada por ige |
| EP1709077A1 (en) | 2004-01-30 | 2006-10-11 | Suomen Punainen Risti Veripalvelu | Process for the manufacture of virus safe immunoglobulin |
| WO2005082109A2 (en) | 2004-02-26 | 2005-09-09 | Massachusetts Institute Of Technology | Solution additives for the attenuation of protein aggregation |
| EP1780830A1 (en) | 2004-08-19 | 2007-05-02 | Electronic Navigation Research Institute, an Independent Administrative Institution | Device using dielectric lens |
| US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| JP6044754B2 (ja) | 2012-01-19 | 2016-12-14 | 株式会社ジェイテクト | クラッチプレートおよびその製造方法 |
| US11220362B2 (en) | 2017-08-16 | 2022-01-11 | O & M Halyard, Inc. | Method and system for wrapping ties in a facemask manufacturing process |
-
2005
- 2005-09-06 US US11/220,362 patent/US20060051347A1/en not_active Abandoned
- 2005-09-07 MY MYPI20104600 patent/MY150549A/en unknown
- 2005-09-07 MY MYPI20054224A patent/MY162525A/en unknown
- 2005-09-07 TW TW094130719A patent/TWI372630B/zh not_active IP Right Cessation
- 2005-09-08 PL PL10009914.2T patent/PL2292636T3/pl unknown
- 2005-09-08 BR BRPI0515649A patent/BRPI0515649B8/pt active IP Right Grant
- 2005-09-08 PT PT221781172T patent/PT4108259T/pt unknown
- 2005-09-08 AU AU2005285243A patent/AU2005285243C1/en not_active Expired
- 2005-09-08 HU HUE10009914A patent/HUE065025T2/hu unknown
- 2005-09-08 PL PL20200642.5T patent/PL3805248T3/pl unknown
- 2005-09-08 EP EP22178156.0A patent/EP4104859B1/en not_active Expired - Lifetime
- 2005-09-08 SI SI200532316T patent/SI2292636T1/sl unknown
- 2005-09-08 ES ES05806393.4T patent/ES2528541T3/es not_active Expired - Lifetime
- 2005-09-08 ES ES10009914T patent/ES2968070T3/es not_active Expired - Lifetime
- 2005-09-08 LT LTEP22178156.0T patent/LT4104859T/lt unknown
- 2005-09-08 ES ES20200642T patent/ES2942574T3/es not_active Expired - Lifetime
- 2005-09-08 CN CN2012103764183A patent/CN102911268A/zh active Pending
- 2005-09-08 EP EP10009914.2A patent/EP2292636B9/en not_active Expired - Lifetime
- 2005-09-08 PL PL05806393T patent/PL1786830T3/pl unknown
- 2005-09-08 ZA ZA200701626A patent/ZA200701626B/xx unknown
- 2005-09-08 PT PT58063934T patent/PT1786830E/pt unknown
- 2005-09-08 KR KR1020127030933A patent/KR101528970B1/ko not_active Expired - Lifetime
- 2005-09-08 PL PL22178117.2T patent/PL4108259T3/pl unknown
- 2005-09-08 FI FIEP10009914.2T patent/FI2292636T3/fi active
- 2005-09-08 EP EP22178117.2A patent/EP4108259B1/en not_active Expired - Lifetime
- 2005-09-08 FI FIEP22178156.0T patent/FI4104859T3/fi active
- 2005-09-08 MX MX2007002812A patent/MX2007002812A/es not_active Application Discontinuation
- 2005-09-08 HU HUE22178156A patent/HUE067662T2/hu unknown
- 2005-09-08 RU RU2007110534/13A patent/RU2390524C2/ru active
- 2005-09-08 KR KR1020077007862A patent/KR20070109975A/ko not_active Ceased
- 2005-09-08 SI SI200532312T patent/SI3805248T1/sl unknown
- 2005-09-08 PT PT202006425T patent/PT3805248T/pt unknown
- 2005-09-08 DK DK05806393.4T patent/DK1786830T3/en active
- 2005-09-08 PT PT221781560T patent/PT4104859T/pt unknown
- 2005-09-08 LT LTEP10009914.2T patent/LT2292636T/lt unknown
- 2005-09-08 ES ES22178156T patent/ES2983099T3/es not_active Expired - Lifetime
- 2005-09-08 ES ES22178117T patent/ES2975166T3/es not_active Expired - Lifetime
- 2005-09-08 NZ NZ553239A patent/NZ553239A/en not_active IP Right Cessation
- 2005-09-08 WO PCT/US2005/031844 patent/WO2006031560A2/en not_active Ceased
- 2005-09-08 SG SG2011088622A patent/SG177161A1/en unknown
- 2005-09-08 LT LTEP22178117.2T patent/LT4108259T/lt unknown
- 2005-09-08 DK DK22178156.0T patent/DK4104859T3/da active
- 2005-09-08 CN CN201510468312.XA patent/CN104961797B/zh not_active Expired - Lifetime
- 2005-09-08 DK DK10009914.2T patent/DK2292636T3/da active
- 2005-09-08 FI FIEP20200642.5T patent/FI3805248T3/fi active
- 2005-09-08 SI SI200531932T patent/SI1786830T1/sl unknown
- 2005-09-08 EP EP05806393.4A patent/EP1786830B1/en not_active Revoked
- 2005-09-08 SI SI200532319T patent/SI4104859T1/sl unknown
- 2005-09-08 EP EP20200642.5A patent/EP3805248B1/en not_active Expired - Lifetime
- 2005-09-08 FI FIEP22178117.2T patent/FI4108259T3/fi active
- 2005-09-08 MX MX2012011125A patent/MX342788B/es unknown
- 2005-09-08 LT LTEP20200642.5T patent/LT3805248T/lt unknown
- 2005-09-08 DK DK22178117.2T patent/DK4108259T3/da active
- 2005-09-08 SI SI200532317T patent/SI4108259T1/sl unknown
- 2005-09-08 HU HUE22178117A patent/HUE067296T2/hu unknown
- 2005-09-08 PL PL22178156.0T patent/PL4104859T3/pl unknown
- 2005-09-08 HU HUE20200642A patent/HUE061899T2/hu unknown
- 2005-09-08 CN CN200580038351.0A patent/CN101056885B/zh not_active Expired - Lifetime
- 2005-09-08 CA CA2577317A patent/CA2577317C/en not_active Expired - Lifetime
- 2005-09-08 DK DK20200642.5T patent/DK3805248T5/da active
- 2005-09-08 JP JP2007531302A patent/JP5210633B2/ja not_active Expired - Lifetime
- 2005-09-08 PT PT100099142T patent/PT2292636T/pt unknown
- 2005-09-09 AR ARP050103779A patent/AR050641A1/es active IP Right Grant
- 2005-09-09 GT GT200500254A patent/GT200500254A/es unknown
- 2005-09-09 PE PE2005001049A patent/PE20060816A1/es active IP Right Grant
-
2006
- 2006-09-29 US US11/537,577 patent/US20070237762A1/en not_active Abandoned
-
2007
- 2007-02-15 IL IL181372A patent/IL181372A/en active IP Right Grant
- 2007-02-23 TN TNP2007000069A patent/TNSN07069A1/en unknown
- 2007-02-28 EC EC2007007282A patent/ECSP077282A/es unknown
- 2007-03-16 NO NO20071432A patent/NO333660B1/no unknown
- 2007-04-06 MA MA29809A patent/MA28991B1/fr unknown
-
2009
- 2009-02-19 US US12/389,140 patent/US20090214522A1/en not_active Abandoned
-
2011
- 2011-11-24 JP JP2011256451A patent/JP5426641B2/ja not_active Expired - Lifetime
- 2011-12-08 IL IL216851A patent/IL216851A0/en unknown
-
2014
- 2014-04-21 US US14/257,907 patent/US10370456B2/en not_active Expired - Lifetime
-
2020
- 2020-09-10 US US17/017,465 patent/US12371510B2/en active Active
-
2022
- 2022-11-01 US US17/978,913 patent/US11767370B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012097086A5 (cg-RX-API-DMAC7.html) | ||
| JP2013514381A5 (cg-RX-API-DMAC7.html) | ||
| WO2013021279A3 (en) | Highly galactosylated antibodies | |
| EA033455B1 (ru) | Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе | |
| HK1198442A1 (en) | Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof | |
| WO2014060375A3 (en) | 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group | |
| JP2014521346A5 (cg-RX-API-DMAC7.html) | ||
| IL216935A (en) | Process for making if the pearl is mechanically designed by mechanical synthesis, if the pearl is designed so mechanically and applied | |
| IL232976A0 (en) | Antibodies that bind to epitopes of the influenza A virus, preparations containing them and methods for their preparation | |
| WO2011100508A3 (en) | Methods and compositions related to glycoprotein-immunoglobulin fusions | |
| JP2014507254A5 (cg-RX-API-DMAC7.html) | ||
| WO2014144153A3 (en) | Metapneumovirus immunogens and related materials and methods | |
| WO2011139752A3 (en) | Preparation of polypeptides and salts thereof | |
| CN301933338S (zh) | 水壶（gs3lt） | |
| CN302333223S (zh) | 超声波清洗机内桶(cd-4890gt) | |
| CN302092351S (zh) | 超声波清洗机内桶(cd-7810gt) | |
| CN302054553S (zh) | 超声波清洗机内桶(cd-7920gt) | |
| CN302054551S (zh) | 超声波清洗机内桶(cd-4830gt) | |
| CN301973213S (zh) | 椅子（gs-g1795b） | |
| CN302421043S (zh) | 提手（海豚） | |
| CN302054549S (zh) | 超声波清洗机内桶（cd-4810gt） | |
| CN302031342S (zh) | 电动童车（双人座卡丁车zp6058） | |
| CN301964620S (zh) | 汤锅（gt22g） | |
| CN301939519S (zh) | 双摆铣头(gm28) | |
| CN302080685S (zh) | 婴儿车用托架 |